WNS vs. HQY, BILI, MEDP, WPP, LYFT, AMTM, SEZL, MARA, ETSY, and WSC
Should you be buying WNS stock or one of its competitors? The main competitors of WNS include HealthEquity (HQY), Bilibili (BILI), Medpace (MEDP), WPP (WPP), Lyft (LYFT), Amentum (AMTM), Sezzle (SEZL), Marathon Digital (MARA), Etsy (ETSY), and WillScot (WSC). These companies are all part of the "business services" industry.
WNS vs. Its Competitors
WNS (NYSE:WNS) and HealthEquity (NASDAQ:HQY) are both mid-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk.
WNS currently has a consensus target price of $62.25, indicating a potential downside of 4.79%. HealthEquity has a consensus target price of $118.09, indicating a potential upside of 18.62%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than WNS.
WNS has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, HealthEquity has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500.
97.4% of WNS shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 2.0% of WNS shares are held by company insiders. Comparatively, 1.5% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
WNS has a net margin of 12.94% compared to HealthEquity's net margin of 9.80%. WNS's return on equity of 23.26% beat HealthEquity's return on equity.
In the previous week, HealthEquity had 12 more articles in the media than WNS. MarketBeat recorded 14 mentions for HealthEquity and 2 mentions for WNS. WNS's average media sentiment score of 0.93 beat HealthEquity's score of 0.91 indicating that WNS is being referred to more favorably in the media.
WNS has higher revenue and earnings than HealthEquity. WNS is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.
Summary
WNS beats HealthEquity on 9 of the 17 factors compared between the two stocks.
Get WNS News Delivered to You Automatically
Sign up to receive the latest news and ratings for WNS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding WNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NYSE:WNS) was last updated on 7/4/2025 by MarketBeat.com Staff
